FESTUCCIA, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 2.926
EU - Europa 1.589
AS - Asia 1.565
SA - Sud America 287
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 6.411
Nazione #
US - Stati Uniti d'America 2.862
SG - Singapore 738
IE - Irlanda 424
CN - Cina 354
DE - Germania 303
BR - Brasile 254
HK - Hong Kong 182
IT - Italia 170
SE - Svezia 161
RU - Federazione Russa 148
TR - Turchia 92
GB - Regno Unito 90
UA - Ucraina 83
VN - Vietnam 78
FI - Finlandia 61
CA - Canada 42
FR - Francia 35
IN - India 34
BE - Belgio 33
CZ - Repubblica Ceca 25
BD - Bangladesh 17
JP - Giappone 17
ZA - Sudafrica 16
PL - Polonia 15
MX - Messico 12
AR - Argentina 11
ES - Italia 11
NL - Olanda 10
IQ - Iraq 8
MA - Marocco 8
PK - Pakistan 8
LT - Lituania 7
EC - Ecuador 6
KR - Corea 6
EU - Europa 5
AE - Emirati Arabi Uniti 4
UY - Uruguay 4
VE - Venezuela 4
CO - Colombia 3
ID - Indonesia 3
KZ - Kazakistan 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
GY - Guiana 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
BH - Bahrain 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
LU - Lussemburgo 1
LY - Libia 1
NO - Norvegia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
Totale 6.411
Città #
Dallas 472
Chandler 453
Dublin 420
Singapore 405
Jacksonville 319
Hong Kong 182
Ashburn 175
Santa Clara 127
Ann Arbor 103
New York 103
Boardman 92
Munich 92
Beijing 70
Izmir 59
L'aquila 58
Nanjing 57
Wilmington 57
Bremen 53
Lawrence 53
Princeton 53
Los Angeles 46
Grafing 38
Woodbridge 38
The Dalles 37
Moscow 36
Brussels 32
San Mateo 27
Columbus 26
Shenyang 24
Seattle 23
Brno 22
Helsinki 22
Nanchang 21
São Paulo 19
Turku 19
Ho Chi Minh City 17
Hanoi 16
Tokyo 16
Falls Church 15
Montreal 15
Rome 15
Stockholm 15
Kunming 14
Tianjin 14
Johannesburg 13
Warsaw 13
Brooklyn 12
Dong Ket 12
Frankfurt am Main 12
L’Aquila 12
Milan 12
Berlin 11
Council Bluffs 11
Houston 11
Toronto 11
Dearborn 10
Falkenstein 10
Mountain View 10
Orem 10
Belo Horizonte 9
Changsha 9
Chennai 9
Des Moines 9
Phoenix 9
Shanghai 9
Washington 9
Amsterdam 8
Atlanta 8
Chicago 8
Denver 8
Hebei 8
Jinan 8
London 8
Norwalk 8
San Francisco 8
Ankara 7
Boston 7
Da Nang 7
Manchester 7
Poplar 7
Pune 7
Haiphong 6
Hanover 6
Hefei 6
Jiaxing 6
Mexico City 6
Mumbai 6
Napoli 6
Seoul 6
Curitiba 5
Dhaka 5
Lappeenranta 5
Rio de Janeiro 5
Verona 5
Zhengzhou 5
Baghdad 4
Montevideo 4
New Delhi 4
Ningbo 4
Querétaro 4
Totale 4.415
Nome #
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 178
C-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines 173
From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis 158
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 154
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 148
Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds 143
PPARγ-dependent effects of conjugated linoleic acid on a human glioblastoma cell line (ADF) 139
Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgenindependent prostate cancer cells to DNA damage 134
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 133
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 132
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 130
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 129
Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse 128
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human Glioblastoma 128
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 126
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 123
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 123
Tebuconazole and Econazole Act Synergistically in Mediating Mitochondrial Stress, Energy Imbalance, and Sequential Activation of Autophagy and Apoptosis in Mouse Sertoli TM4 Cells: Possible Role of AMPK/ULK1 Axis 123
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 121
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 121
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 121
Suppression of SRC signaling is effective in reducing synergy between glioblastoma and stromal cells 119
Lactobacillus sakei pro-bio65 reduces tnf-α expression and upregulates gsh content and antioxidant enzymatic activities in human conjunctival cells 117
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 115
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer 115
Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells 115
Episode-like pulse testosterone supplementation induces tumor senescence and growth arrest down-modulating androgen receptor through modulation of p-ERK1/2, pARser81 and CDK1 signaling: biological implications for men treated with testosterone replacement therapy 113
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models 113
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 112
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 109
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 108
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth 108
ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma 108
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 107
Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps? 107
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma 107
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 106
Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis 105
The possible prognostic role of histone deacetylase and transforming growth factor β/Smad signaling in high grade gliomas treated by radio-chemotherapy: a preliminary immunohistochemical study 104
Editorial: Antitarget Therapies: New Frontiers in the Treatment of Cancer 104
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 104
KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and surviving in prostate cancer models 103
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 103
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling 96
The importance of tumor stem cells in glioblastoma resistance to therapy 95
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 93
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models 91
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model. 90
Editorial: New Drug Targets for Treatment of Recurrent/Metastatic Prostate Cancer 88
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models 86
Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models 85
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. 84
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties 77
New therapeutic approaches for the treatmemt of glioblastoma 76
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 68
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 60
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 53
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 51
A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence 45
Targeted molecular therapy in glioblastoma 34
Totale 6.539
Categoria #
all - tutte 27.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 17 57 6 65 23 71 30
2021/2022399 22 3 68 25 12 54 16 14 35 37 25 88
2022/20231.236 73 93 18 173 105 120 0 92 502 11 30 19
2023/2024351 42 13 20 13 26 135 10 12 1 9 17 53
2024/20251.503 39 31 98 104 169 126 214 126 280 103 130 83
2025/20261.700 154 281 391 418 319 137 0 0 0 0 0 0
Totale 6.539